Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
about
Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapyCurrent and potential treatments for ubiquitous but neglected herpesvirus infectionsHydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogsSelection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanineMode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89Simultaneous determination of acyclovir, ganciclovir, and (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in human plasma using high-performance liquid chromatography.Emerging drugs for varicella-zoster virus infections.Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyUpdate on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.Progress in the development of new therapies for herpesvirus infectionsAchievements and challenges in antiviral drug discovery.Main adult herpes virus infections of the CNS.Antimicrobial strategies: inhibition of viral polymerases by 3'-hydroxyl nucleosides.Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B infected cellsAnti-herpesvirus agents: a patent and literature review (2003 to present).Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.
P2860
Q24672068-7B72CB01-420A-4F7A-83DA-A4964138A3A7Q27023452-FC891A8F-4C46-475C-AA5D-00B0A17F0FFDQ28343742-DEC011B6-A53B-4D6D-B551-BBC22654C741Q28365190-72B2B2CD-835C-4547-A3AD-636D71334AA8Q28368325-424660A4-4FCA-4A3A-A708-BE95478ADC7DQ28369328-D6A02A8A-E2B3-4D1A-B33B-5F2EA7DDCF54Q28378905-2563069D-5580-4830-906B-23FD2C5C5176Q33428636-E4B40789-8F2C-4AE1-90CE-97EEF381F330Q34027426-704FD617-C62E-43E8-A17F-8FBB373D49F6Q34579981-B95F620D-3C2A-4736-AEB2-7BFE4FEFBCA2Q35531731-79EE2DFD-64BF-4458-8231-47E95A582702Q35590695-DA8D9137-A6C2-43B2-9768-D92913C74113Q36186792-BD1F9D59-14A8-4C67-8E26-906C01E1DFE0Q36233543-D88D3F3C-A387-4E76-A59C-336D32508E1FQ37396435-6CE37F04-A292-4F1E-9994-7B5CC3FBD804Q37561897-97E1E580-6E55-4566-A0F3-5A268DC5045CQ38228015-769B5CC4-47AC-449B-AE2F-5D4B29FDDC2DQ41722018-B16A788C-F985-4969-B380-4E1BA4777790Q43405240-4C2D00E9-DA58-4E6E-9D46-46A974683577
P2860
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
@ast
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
@en
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
@nl
type
label
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
@ast
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
@en
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
@nl
prefLabel
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
@ast
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
@en
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
@nl
P2093
P2860
P356
P1476
Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses
@en
P2093
G B Roberts
R Gaillard
W H Miller
P2860
P304
P356
10.1128/AAC.39.8.1802
P407
P577
1995-08-01T00:00:00Z